RARA CRAFT DATABASE for FDA Medical Devices
510(k)K180129

FDA DEVICE FACTS

Imbio Segmentation Editing Tool software

Imbio, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 16, 2018PRODUCT CODELLZ

Indications for use

Segmentation Editing Tool Software is intended for use by trained medical professionals including, but not limited to, radiologists, oncologists and medical imaging technologists. It is intended to locally correct errors in the segmentation masks produced by Imbio’s automatic segmentation algorithms Additionally, if the Imbio segmentation algorithm is unable to produce a segmentation mask, this tool could be used to semi-manually create a segmentation mask. The application will be accessed most typically from a PACS workstation over a modern Internet browser (e.g. IE>10). Traditional 510(k) Premarket Submission Imbio Segmentation Editing Tool Software Confidential 510(k) Summary (As required by Section 21 CFR 807.92(c)) Summary of Technical Comparisons The fundamental functional characteristics of SET are very similar to the analogous functions included in MIM 5.2 (Brachy). The primary differences between the proposed and predicate devices are that: • Imbio SET is not a standalone application and can only be used in conjunction with other Imbio algorithms installed on Imbio’s platform. • Imbio SET has contour snapping and interpolation features that serve as workflow optimization tools for contouring tasks involving large regions of interest. • Imbio SET has a much more limited set of features than MIM 5.2 (Brachy). Non-Clinical Testing Non-clinical testing was done to show validity of SET software. Results can be seen in Software Test Protocol/Report attached in Appendix E/Appendix F Design Validation Design validation was performed using the Imbio Segmentation Editing Tool Software in actual and simulated use settings. Clinical Testing This technology is not new; therefore, a clinical study was not considered necessary prior to release. Additionally, there was no clinical testing required to support the medical device as the indications for use is equivalent to the predicate device. Usability testing was completed for this product to ensure proper use of the product by intended users.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026